Thesite is secure.
The ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
Findings: Participants reported anxiety, referring to 'wait and worry'. Their information needs were not met, and they resorted to seeking information on possible future treatments themselves. They also experienced feeling like an imposter because they were not receiving active treatment like other patients with cancer.
Conclusions: A greater understanding of how information provision affects levels of anxiety and worry among people living with CLL on watch and wait is needed. In addition, clinical nurse specialists could deliver education on the watch and wait approach, supplemented by video-based educational materials developed by the haematology team.
DS wants to buy the box set with his birthday money.
The synopsis sounds like perfect 14 year old boy humour, but is it suitable?
He's 14 and the DVD is 18 rated, would it contain stuff that wasn't broacast on tv?.
I think I would let a 14 year old watch it - to my (40 year old woman) mind, it is very realistic about teenage boys, and it is VERY funny.
I definitely would not let my 10 year old and almost 13 year old dds watch it - even though they would love to.
I was a bit when I found out (on Twitter) that Jon Ronson lets his 11 year old son watch it - I even asked him (the son) if his parents knew he was watching it, and he told me they didn't mind...
I started to watch it with 12 year old ds and of course he thought it was hysterical, as I did, but I turned it over in the end as it was a bit too much.
Not sure about 14 though. Why don't you watch a couple of episodes and see. They are on at the moment, I think. On E4?
I, as a middle-aged woman find it hysterial and am looking forward to the 3rd series. I I would let a 14 year old watch it with my approval - it is just full of talk of sex and swearing etc but that's their world, isn't it and it does actually treat some of those coming of age issues very well.
Thanks everyone. I thought it would be ok it was just the 18 tag. I know it's exactly his sort of humour. Will record an episode and watch it, preferably on my own. Or get DH to watch it (although he thinks Mock the Week is ok ).
I also think it's hilarious - don't think my 14 yo saw it as he was a bit younger when I watched it.
I know he'd love it, but we'd have to keep fast-forwarding through some scenes - I'm thinking in particular of the one where the boy wanks over a photo of a woman in a bikini when he's working in an old people's home, and just at the point of no return the family come in, THEN the old lady proudly announces from her bed, 'he did that over me.'
Hysterically funny, but, believe me, masturbation is not just talked about, and not something any 14 yo would want to watch with his mother.
oh yes, do let them watch it. I find it fucking hilarious (as a 39 year old woman) because it is just like being 14/15/16. Unless your son has lived a very sheltered life there won't be anything on there that he hasn't seen/heard about/experienced for himself. It's totally suitable imho
Nrgaard CH, Sgaard NB, Biccler JL Limited value of routine follow-up visits in chronic lymphocytic leukemia managed initially by watch and wait: a North Denmark population-based study. PLoS One. 2018; 13:(12)
Chronic lymphocytic leukaemia (CLL) is the most common adult leukaemia in the western world; it is incurable and typically occurs in people aged over 60 years (Mukkamalla et al, 2023). The average age at diagnosis of CLL is 71 years and it is more common in men (American Society of Clinical Oncology (ASCO), 2017). Diagnosis is usually discovered incidentally when lymphocytosis is observed in a complete blood cell count (Muchtar et al, 2020).
Patients with asymptomatic, early-stage CLL are managed with a watch and wait (watch and wait) or active surveillance strategy, and treatment started only with symptomatic disease (Hallek et al, 2018). This follows evidence from clinical trials showing no advantage in survival from treatment of chlorambucil and fludarabine versus placebo in asymptomatic CLL patients (Dighiero et al, 1998; Hoechstetter et al, 2017) or with watch and wait versus early treatment with fludarabine, cyclophosphamide and rituximab (Herling et al, 2020). Moreover, although the recent results from the CLL12 clinical trial, which compared ibrutinib with placebo, show a higher progression-free survival in patients receiving ibrutinib, further results are needed to demonstrate an advantage of ibrutinib over observation in overall survival (Langerbeins et al, 2019).
3a8082e126